Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.66
-0.01 (-0.22%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Harvard Bioscience Revenue
Harvard Bioscience had revenue of $22.73M in the quarter ending June 30, 2026, with 11.13% growth. This brings the company's revenue in the last twelve months to $87.81M, down -1.06% year-over-year. In the year 2025, Harvard Bioscience had annual revenue of $86.55M, down -8.06%.
Revenue (ttm)
$87.81M
Revenue Growth
-1.06%
P/S Ratio
0.35
Revenue / Employee
$259,021
Employees
339
Market Cap
30.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 86.55M | -7.59M | -8.06% |
| Dec 31, 2024 | 94.14M | -18.12M | -16.14% |
| Dec 31, 2023 | 112.25M | -1.09M | -0.96% |
| Dec 31, 2022 | 113.34M | -5.57M | -4.68% |
| Dec 31, 2021 | 118.90M | 16.80M | 16.46% |
| Dec 31, 2020 | 102.10M | -14.08M | -12.12% |
| Dec 31, 2019 | 116.18M | -4.60M | -3.81% |
| Dec 31, 2018 | 120.77M | 43.37M | 56.02% |
| Dec 31, 2017 | 77.41M | -27.11M | -25.94% |
| Dec 31, 2016 | 104.52M | -4.14M | -3.81% |
| Dec 31, 2015 | 108.66M | 1,000.00 | - |
| Dec 31, 2014 | 108.66M | 3.49M | 3.32% |
| Dec 31, 2013 | 105.17M | -6.00M | -5.40% |
| Dec 31, 2012 | 111.17M | 2.31M | 2.12% |
| Dec 31, 2011 | 108.86M | 685.00K | 0.63% |
| Dec 31, 2010 | 108.18M | 22.41M | 26.12% |
| Dec 31, 2009 | 85.77M | -2.28M | -2.59% |
| Dec 31, 2008 | 88.05M | 4.64M | 5.57% |
| Dec 31, 2007 | 83.41M | 7.23M | 9.49% |
| Dec 31, 2006 | 76.18M | 8.75M | 12.98% |
| Dec 31, 2005 | 67.43M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Retractable Technologies | 33.90M |
| Bionano Genomics | 30.18M |
| Precision Optics Corporation | 28.94M |
| Nephros | 20.72M |
| Jin Medical International | 19.73M |
| Milestone Scientific | 9.42M |
| Femasys | 2.30M |
| Zentek | 76.23K |
HBIO News
- 5 days ago - Harvard Bioscience Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Harvard Bioscience Earnings release: Q2 2026 - Filings
- 5 days ago - Harvard Bioscience Slides: Q2 2026 - Filings
- 5 days ago - Harvard Bioscience Quarterly report: Q2 2026 - Filings
- 19 days ago - Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET - GlobeNewsWire
- 2 months ago - Harvard Bioscience management to meet with KeyBanc - TheFly
- 2 months ago - Harvard Bioscience Transcript: AGM 2026 - Transcripts
- 3 months ago - Harvard Bioscience Transcript: Sidoti Micro-Cap Virtual Conference - Transcripts